异基因造血干细胞移植重症监护病房候选资格的范式转变：哪些人、何时以及持续多久？ - Suppr

Paradigm Shift in ICU Candidacy for Allogeneic Hematopoietic Stem Cell Transplantation: Who, When, and How Long?

作者信息

García-de-Acilu Marina, Munshi Laveena, Roca Oriol

机构信息

Servei de Medicina Intensiva, Parc Taulí Hospital Universitari Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA) Sabadell, Spain.

Departament de Medicina Universitat Autònoma de Barcelona Bellaterra, Spain.

出版信息

Am J Respir Crit Care Med. 2024 Oct 15;210(8):971-973. doi: 10.1164/rccm.202407-1496ED.

DOI:10.1164/rccm.202407-1496ED

PMID:39236266

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11531099/

Abstract

摘要

相似文献

Paradigm Shift in ICU Candidacy for Allogeneic Hematopoietic Stem Cell Transplantation: Who, When, and How Long?异基因造血干细胞移植重症监护病房候选资格的范式转变：哪些人、何时以及持续多久？

Am J Respir Crit Care Med. 2024 Oct 15;210(8):971-973. doi: 10.1164/rccm.202407-1496ED.

Advance Directive Utilization Is Associated with Less Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.预先指示的使用与异基因造血细胞移植患者的临终关怀不那么激进有关。

Biol Blood Marrow Transplant. 2018 May;24(5):1035-1040. doi: 10.1016/j.bbmt.2018.01.014. Epub 2018 Jan 31.

Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation.异基因干细胞移植后入住重症监护病房的危重症患者短期和长期死亡率的预测因素。

Bone Marrow Transplant. 2019 Mar;54(3):418-424. doi: 10.1038/s41409-018-0277-3. Epub 2018 Aug 6.

Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit.减低强度预处理方案后异基因造血干细胞移植：入住重症监护病房患者的结局

J Crit Care. 2015 Oct;30(5):1107-13. doi: 10.1016/j.jcrc.2015.06.020. Epub 2015 Jun 24.

Autoimmune-like hepatitis after allogeneic hematopoietic stem cell transplantation: humoral hepatic GvHD.异基因造血干细胞移植后类似自身免疫性肝炎：体液性肝脏移植物抗宿主病

Bone Marrow Transplant. 2017 Jan;52(1):151-153. doi: 10.1038/bmt.2016.202. Epub 2016 Aug 15.

Age does not matter: Mobilization and harvesting are safe and effective for elderly allogeneic peripheral hematopoietic stem cell donors.年龄并非问题：动员和采集对于老年异基因外周血造血干细胞供者而言是安全有效的。

Transfus Apher Sci. 2017 Dec;56(6):825-828. doi: 10.1016/j.transci.2017.11.014. Epub 2017 Nov 8.

Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.HIV 阴性复发性浆母细胞淋巴瘤患者行异基因造血干细胞移植：病例报告。

Medicine (Baltimore). 2021 Feb 19;100(7):e24498. doi: 10.1097/MD.0000000000024498.

Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation.造血干细胞移植后在重症监护病房接受治疗的患者的长期预后

Int J Hematol. 2018 Dec;108(6):622-629. doi: 10.1007/s12185-018-2536-x. Epub 2018 Sep 20.

Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study.异基因造血干细胞移植受者的药物依从性：一项单中心试点研究。

Bone Marrow Transplant. 2018 Feb;53(2):231-233. doi: 10.1038/bmt.2017.233. Epub 2017 Nov 20.

Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation.0/10 HLA 错配的无关供者异基因造血干细胞移植后实现完全供者嵌合状态

Bone Marrow Transplant. 2018 Dec;53(12):1578-1582. doi: 10.1038/s41409-018-0229-y. Epub 2018 Jun 8.

本文引用的文献

Outcomes in Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients.危重症异基因造血干细胞移植受者的结局。

Am J Respir Crit Care Med. 2024 Oct 15;210(8):1017-1024. doi: 10.1164/rccm.202401-0135OC.

Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study.血液系统恶性肿瘤重症患者的长期生存及功能转归：一项加拿大多中心前瞻性研究

Intensive Care Med. 2024 Apr;50(4):561-572. doi: 10.1007/s00134-024-07349-z. Epub 2024 Mar 11.

Impact of pre-transplant individual comorbidities on risk of ICU admission and survival outcomes following allogeneic hematopoietic stem cell transplantation.移植前个体合并症对异基因造血干细胞移植后入住重症监护病房的风险及生存结局的影响。

Bone Marrow Transplant. 2023 Mar;58(3):311-316. doi: 10.1038/s41409-022-01897-y. Epub 2022 Dec 12.

One million haemopoietic stem-cell transplants: a retrospective observational study.一百万例造血干细胞移植：一项回顾性观察研究。

Lancet Haematol. 2015 Mar;2(3):e91-100. doi: 10.1016/S2352-3026(15)00028-9. Epub 2015 Feb 27.

Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study.危重病血液病患者的转归：来自法国和比利时的前瞻性多中心数据——一个肿瘤科危重病呼吸研究组的研究。

J Clin Oncol. 2013 Aug 1;31(22):2810-8. doi: 10.1200/JCO.2012.47.2365. Epub 2013 Jun 10.

Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.肝静脉闭塞病（VOD）继造血干细胞移植后：发病率、临床病程和结果。

Biol Blood Marrow Transplant. 2010 Feb;16(2):157-68. doi: 10.1016/j.bbmt.2009.08.024. Epub 2009 Sep 18.

Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.危重症异基因造血干细胞移植受者的结局：对器官功能衰竭支持指征的重新评估

J Clin Oncol. 2006 Feb 1;24(4):643-9. doi: 10.1200/JCO.2005.03.9073. Epub 2005 Dec 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Paradigm Shift in ICU Candidacy for Allogeneic Hematopoietic Stem Cell Transplantation: Who, When, and How Long?

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献